Navamedic ASA (NAVA) - Total Assets
Based on the latest financial reports, Navamedic ASA (NAVA) holds total assets worth Nkr656.62 Million NOK (≈ $69.10 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Navamedic ASA - Total Assets Trend (2003–2025)
This chart illustrates how Navamedic ASA's total assets have evolved over time, based on quarterly financial data. Also see Navamedic ASA market cap and net worth for the company's overall valuation and market capitalisation.
Navamedic ASA - Asset Composition Analysis
Current Asset Composition (December 2025)
Navamedic ASA's total assets of Nkr656.62 Million consist of 36.7% current assets and 63.4% non-current assets. Review how much debt does Navamedic ASA carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr72.57 Million | 9.8% |
| Accounts Receivable | Nkr43.30 Million | 5.8% |
| Inventory | Nkr116.56 Million | 15.7% |
| Property, Plant & Equipment | Nkr6.19 Million | 0.8% |
| Intangible Assets | Nkr250.89 Million | 33.8% |
| Goodwill | Nkr207.57 Million | 28.0% |
Asset Composition Trend (2003–2025)
This chart illustrates how Navamedic ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See NAVA stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Navamedic ASA's current assets represent 36.7% of total assets in 2025, a decrease from 51.8% in 2003.
- Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, down from 335.6% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 30.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 33.8% of total assets.
Navamedic ASA Competitors by Total Assets
Key competitors of Navamedic ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Limited
F:S5YA
|
Germany | €1.83 Billion |
|
China National Medicines Corp Ltd
SHG:600511
|
China | CN¥35.13 Billion |
|
China National Accord Medicines Corp Ltd
SHE:200028
|
China | HK$49.12 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
Navamedic ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 1.30 | 1.13 |
| Quick Ratio | 0.74 | 0.71 | 0.58 |
| Cash Ratio | 0.00 | 0.25 | 0.17 |
| Working Capital | Nkr74.89 Million | Nkr50.72 Million | Nkr17.28 Million |
Navamedic ASA - Advanced Valuation Insights
This section examines the relationship between Navamedic ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.06 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 51.0% |
| Total Assets | Nkr741.75 Million |
| Market Capitalization | $33.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Navamedic ASA's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Navamedic ASA's assets grew by 51.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Navamedic ASA (2003–2025)
The table below shows the annual total assets of Navamedic ASA from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr741.75 Million ≈ $78.05 Million |
+50.99% |
| 2024-12-31 | Nkr491.24 Million ≈ $51.69 Million |
-6.31% |
| 2023-12-31 | Nkr524.30 Million ≈ $55.17 Million |
+36.98% |
| 2022-12-31 | Nkr382.77 Million ≈ $40.28 Million |
+15.93% |
| 2021-12-31 | Nkr330.18 Million ≈ $34.74 Million |
+26.97% |
| 2020-12-31 | Nkr260.04 Million ≈ $27.36 Million |
+39.02% |
| 2019-12-31 | Nkr187.06 Million ≈ $19.68 Million |
-12.89% |
| 2018-12-31 | Nkr214.73 Million ≈ $22.60 Million |
-13.16% |
| 2017-12-31 | Nkr247.27 Million ≈ $26.02 Million |
-14.04% |
| 2016-12-31 | Nkr287.67 Million ≈ $30.27 Million |
+4.40% |
| 2015-12-31 | Nkr275.55 Million ≈ $29.00 Million |
+29.24% |
| 2014-12-31 | Nkr213.20 Million ≈ $22.44 Million |
+18.79% |
| 2013-12-31 | Nkr179.48 Million ≈ $18.89 Million |
+34.19% |
| 2012-12-31 | Nkr133.75 Million ≈ $14.07 Million |
-3.83% |
| 2011-12-31 | Nkr139.07 Million ≈ $14.63 Million |
+12.77% |
| 2010-12-31 | Nkr123.33 Million ≈ $12.98 Million |
-9.69% |
| 2009-12-31 | Nkr136.55 Million ≈ $14.37 Million |
-14.47% |
| 2008-12-31 | Nkr159.65 Million ≈ $16.80 Million |
-13.92% |
| 2007-12-31 | Nkr185.46 Million ≈ $19.52 Million |
+253.76% |
| 2006-12-31 | Nkr52.42 Million ≈ $5.52 Million |
+9.23% |
| 2005-12-31 | Nkr47.99 Million ≈ $5.05 Million |
+180.89% |
| 2004-12-31 | Nkr17.09 Million ≈ $1.80 Million |
+2116.74% |
| 2003-12-31 | Nkr770.79K ≈ $81.11K |
-- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more